ID   SEBP2_RAT               Reviewed;         846 AA.
AC   Q9QX72;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 116.
DE   RecName: Full=Selenocysteine insertion sequence-binding protein 2 {ECO:0000303|PubMed:10637234};
DE            Short=SECIS-binding protein 2 {ECO:0000303|PubMed:10637234};
GN   Name=Secisbp2; Synonyms=Sbp2 {ECO:0000303|PubMed:10637234};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10637234; DOI=10.1093/emboj/19.2.306;
RA   Copeland P.R., Fletcher J.E., Carlson B.A., Hatfield D.L., Driscoll D.M.;
RT   "A novel RNA binding protein, SBP2, is required for the translation of
RT   mammalian selenoprotein mRNAs.";
RL   EMBO J. 19:306-314(2000).
RN   [2]
RP   FUNCTION.
RC   TISSUE=Testis;
RX   PubMed=10464275; DOI=10.1074/jbc.274.36.25447;
RA   Copeland P.R., Driscoll D.M.;
RT   "Purification, redox sensitivity, and RNA binding properties of SECIS-
RT   binding protein 2, a protein involved in selenoprotein biosynthesis.";
RL   J. Biol. Chem. 274:25447-25454(1999).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-220, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: mRNA-binding protein that binds to the SECIS (selenocysteine
CC       insertion sequence) element present in the 3'-UTR of mRNAs encoding
CC       selenoproteins and facilitates the incorporation of the rare amino acid
CC       selenocysteine (PubMed:10464275, PubMed:10637234). Insertion of
CC       selenocysteine at UGA codons is mediated by SECISBP2 and EEFSEC:
CC       SECISBP2 (1) specifically binds the SECIS sequence once the 80S
CC       ribosome encounters an in-frame UGA codon and (2) contacts the
CC       RPS27A/eS31 of the 40S ribosome before ribosome stalling (By
CC       similarity). (3) GTP-bound EEFSEC then delivers selenocysteinyl-
CC       tRNA(Sec) to the 80S ribosome and adopts a preaccommodated state
CC       conformation (By similarity). (4) After GTP hydrolysis, EEFSEC
CC       dissociates from the assembly, selenocysteinyl-tRNA(Sec) accommodates,
CC       and peptide bond synthesis and selenoprotein elongation occur (By
CC       similarity). {ECO:0000250|UniProtKB:Q96T21,
CC       ECO:0000269|PubMed:10464275, ECO:0000269|PubMed:10637234}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:10637234}. Nucleus
CC       {ECO:0000305|PubMed:10637234}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10637234}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ251245; CAB61692.1; -; mRNA.
DR   RefSeq; NP_076492.1; NM_024002.1.
DR   AlphaFoldDB; Q9QX72; -.
DR   SMR; Q9QX72; -.
DR   STRING; 10116.ENSRNOP00000039532; -.
DR   ChEMBL; CHEMBL2176808; -.
DR   CarbonylDB; Q9QX72; -.
DR   iPTMnet; Q9QX72; -.
DR   PhosphoSitePlus; Q9QX72; -.
DR   PaxDb; 10116-ENSRNOP00000039532; -.
DR   PeptideAtlas; Q9QX72; -.
DR   GeneID; 79049; -.
DR   KEGG; rno:79049; -.
DR   AGR; RGD:620991; -.
DR   CTD; 79048; -.
DR   RGD; 620991; Secisbp2.
DR   eggNOG; ENOG502QUP4; Eukaryota.
DR   InParanoid; Q9QX72; -.
DR   OrthoDB; 253192at2759; -.
DR   PhylomeDB; Q9QX72; -.
DR   PRO; PR:Q9QX72; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:RGD.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0035368; F:selenocysteine insertion sequence binding; IDA:UniProtKB.
DR   GO; GO:0008135; F:translation factor activity, RNA binding; TAS:RGD.
DR   GO; GO:0021884; P:forebrain neuron development; ISO:RGD.
DR   GO; GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; ISO:RGD.
DR   GO; GO:1904571; P:positive regulation of selenocysteine incorporation; IDA:RGD.
DR   GO; GO:0001514; P:selenocysteine incorporation; IDA:UniProtKB.
DR   GO; GO:0021756; P:striatum development; ISO:RGD.
DR   Gene3D; 3.30.1330.30; -; 1.
DR   InterPro; IPR029064; Ribosomal_eL30-like_sf.
DR   InterPro; IPR004038; Ribosomal_eL8/eL30/eS12/Gad45.
DR   InterPro; IPR040051; SECISBP2.
DR   PANTHER; PTHR13284; GH01354P; 1.
DR   PANTHER; PTHR13284:SF9; SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2; 1.
DR   Pfam; PF01248; Ribosomal_L7Ae; 1.
DR   SUPFAM; SSF55315; L30e-like; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Nucleus; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome; RNA-binding.
FT   CHAIN           1..846
FT                   /note="Selenocysteine insertion sequence-binding protein 2"
FT                   /id="PRO_0000097656"
FT   REGION          151..246
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          266..288
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          321..440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          448..467
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          475..613
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          666..687
FT                   /note="RNA-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          774..804
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           370..380
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000305|PubMed:10637234"
FT   COMPBIAS        177..198
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        217..231
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        269..288
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        321..340
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        366..383
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        391..417
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        418..433
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        506..537
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        538..578
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   846 AA;  93300 MW;  416EDFDEA38A4A13 CRC64;
     MASERPREPE GEDSIKLSAD VKPFVPKFAG LNVAWSESSE ACVFPGCAAT YYPFVQESPA
     AEQKMYPEDM AFGAPAFPAQ YVSSEIALHP FAYPTYALES TQSVCSVPTL QYDYSQAQCH
     PGFRPAKPRN EHACPPQEAK CVFKKKSSDE RRAWEEQKSS NRRADGAVPC EARPARGSCH
     LKSDGYHKRP DRKSRILTKS ASTSKPEFEF SRLDFPELQS PKNSNLPETQ KQPRWGPLGP
     AASNMSLLGE AGKPVADMVE GKMVKTDHTD GAVTNNAATS SPSCTRELSW TPMGYIVRQT
     VSSDSAAATE TVNSIINLKK TTSSADAKNV SVTSEALSSD PSFSREKRVH PGPKAKASQG
     SELEQNESSK KNKKKKEKSK SSYEVLPVQE PPRIEDAEEF PNLSVASERR HRGESPKLQS
     KQQAQNDFKT GGKKSQVPVQ LDLGGMLAAL EKQQHAPHAK PSSRPVVFSV GAVPVLSKDA
     SSGERGRRSS QVKTPHNPLD SSAPLMKKGK QREIPKAKKP TSLKKIILKE RQERMQQRLQ
     ESAVSPTVAS DDSQDVESGV TNQIPSPDNP TGPEKTEEPM SSTPVVEGES EEPAGTEFQR
     DPEACQPAPD SATFPKIHSR RFRDYCSQML SKEVDACVTG LLKELVRFQD RMYQKDPVKA
     KTKRRLVLGL REVLKHLKLR KLKCIIISPN CEKTQSKGGL DDTLHTIIDC ACEQNIPFVF
     ALNRKALGRS LNKAVPVSIV GIFSYDGAQD QFHKMVELTM AARQAYKTML ETMRQEQAGE
     PGPQTPPSPP MQDPIQSTDE GTLASTGEEP HYIEIWRKHL EAYSQHALEL EDSLEASTSQ
     MMNLNL
//
